首页> 外文期刊>Journal of cellular biochemistry. >Long noncoding RNA CCAT2 functions as a competitive endogenous RNA to regulate FOXC1 expression by sponging miR‐23b‐5p in lung adenocarcinoma
【24h】

Long noncoding RNA CCAT2 functions as a competitive endogenous RNA to regulate FOXC1 expression by sponging miR‐23b‐5p in lung adenocarcinoma

机译:长度非编码RNA CCAT2用作竞争内源性RNA,以通过在肺腺癌中的miR-23b-5p冲压miR-23b-5p来调节foxc1表达

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Long noncoding RNA (lncRNA) may regulate the process of tumor formation. Although lncRNA CCAT2 has been identified as a key point in many diseases, its pathophysiological mechanism in lung adenocarcinoma remains unknown. We measured the expression level of CCAT2 in lung adenocarcinoma cells and normal lung epithelial cell line BEAS‐2B by quantitative real‐time polymerase chain reaction (qRT‐PCR). As well, cell migration and proliferation were detected by transwell detection and CCK8 assay. At the same time, the new target point of CCAT2 was confirmed with bioinformatics analysis and dual‐luciferase reporter assay. In addition, potential mechanisms were studied by Western blot analysis and RNA immunoprecipitation (RIP) analysis. The expression of CCAT2 was upregulated obviously in lung adenocarcinoma cells. Cell function analysis showed that upregulation of CCAT2 significantly promoted cell proliferation and migration, and reduction of CCAT2 inhibited cell migration and proliferation. In addition, CCAT2 positively regulated the expression of FOXC1 by competitive binding with miR‐23b‐5p. These findings indicated that CCAT2 may act as a competitive endogenous RNA (ceRNA) to regulate FOXC1 expression by competitively binding miR‐23b‐5p in lung adenocarcinoma.
机译:摘要长时间的NOODING RNA(LNCRNA)可以调节肿瘤形成的过程。虽然LNCRNA CCAT2已被鉴定为许多疾病中的关键点,但其肺腺癌的病理生理机制仍然未知。通过定量实时聚合酶链反应(QRT-PCR)测量肺腺癌细胞和正常肺上皮细胞系BEAS-2B中CCAT2的表达水平。同样,通过Transwell检测和CCK8测定检测细胞迁移和增殖。同时,用生物信息学分析和双荧光素酶报告结果证实了CCAT2的新目标点。此外,通过蛋白质印迹分析和RNA免疫沉淀(RIP)分析研究了潜在机制。 CCAT2的表达明显在肺腺癌细胞中显而记实。细胞功能分析表明,CCAT2的上调显着促进了细胞增殖和迁移,并减少CCAT2抑制细胞迁移和增殖。此外,CCAT2通过与miR-23b-5p的竞争性结合肯定地调节FoxC1的表达。这些发现表明CCAT2可以作为竞争内源性RNA(CERNA)来调节FOXC1表达,通过竞争地结合肺腺癌中的miR-23b-5p。

著录项

  • 来源
    《Journal of cellular biochemistry.》 |2019年第5期|共10页
  • 作者单位

    Department of Thoracic SurgeryHuai'an Second People's Hospital and The Affiliated Huai'an Hospital;

    Department of Thoracic SurgeryHuai'an Second People's Hospital and The Affiliated Huai'an Hospital;

    Department of Thoracic SurgeryHuai'an Second People's Hospital and The Affiliated Huai'an Hospital;

    Department of Thoracic SurgeryHuai'an Second People's Hospital and The Affiliated Huai'an Hospital;

    Department of Thoracic SurgeryHuai'an Second People's Hospital and The Affiliated Huai'an Hospital;

    Department of Thoracic SurgeryThe No. 82 hospital of PLAChina;

    Department of Thoracic SurgeryHuai'an Second People's Hospital and The Affiliated Huai'an Hospital;

    Department of Thoracic SurgeryHuai'an Second People's Hospital and The Affiliated Huai'an Hospital;

    Department of Thoracic SurgeryHuai'an Second People's Hospital and The Affiliated Huai'an Hospital;

    Department of Thoracic SurgeryHuai'an Second People's Hospital and The Affiliated Huai'an Hospital;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

    ceRNA; FOXC1; lncRNA; lung adenocarcinoma;

    机译:cerna;foxc1;lncrna;肺腺癌;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号